| Financial Year |
March 31 2023 |
| Monetary Funds |
29,714,875.16 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
625,339,651.25 |
| Advances to Suppliers |
3,063,145.84 |
| Other Receivables |
53,364,994.94 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
11,608,929.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
17,527,017.60 |
| Other Current Assets |
20,002,882.58 |
| Total Current Assets |
1,020,058,589.15 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
13,939,166.98 |
| Long-term Equity Investment |
2,371,908.00 |
| Investment Properties |
2,218,819.66 |
| Fixed Assetes |
25,053,876.01 |
| Under-construction Projects |
142,884,136.15 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
14,015,565.35 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
475,098.62 |
| Deferred Income Tax Assets |
76,710,868.24 |
| Other Non-Current Assets |
128,226,792.32 |
| Sub-Total of Non-Current Assets |
418,735,230.15 |
| Total Assets |
1,438,793,819.30 |
| Short-Term Loans |
65,099,041.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
477,813,748.00 |
| Accounts Received In Advance |
261,553.79 |
| Employee Compensation Payable |
20,385,111.05 |
| Taxes Payable |
2,993,452.97 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
253,377,316.46 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
40,552,841.37 |
| Other Current Liabilities |
11,978,065.56 |
| Sub-Total of Current Liabilities |
877,329,388.86 |
| Long-term Loans |
2,227,875.93 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
11,492,502.08 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
832,512.45 |
| Sub-Total of Non-Current Liabilities |
24,538,159.17 |
| Total Liabilities |
901,867,548.03 |
| Paid-In Capital(Or Share Stock) |
695,596,569.00 |
| Capital Surplus |
739,121,523.53 |
| Surplus Reserve |
57,604,711.89 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-955,888,311.61 |
| Minority Stockholder's Interest |
491,778.46 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
536,434,492.81 |
| Owner's Equity（Stockholder's Equity） |
536,926,271.27 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,438,793,819.30 |
